Provectus Pharmaceuticals Inc.'s Patent Application Published for Combining Local and Systemic Therapies for Enhanced Treatment of Cancer
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announced that a patent application has been published for U.S. and international patents covering the combination of local and systemic immunomodulative therapies for cancer treatment.